miR-362-3p suppresses sinonasal squamous cell carcinoma progression via directly targeting pituitary tumor-transforming gene 1

References

• Kawaguchi M, Kato H, Tomita H, et al. Imaging characteristics of malignant sinonasal tumors. J Clin Med. 2017;6(12):116–117.
   Web of Science ®Google Scholar
• Sanghvi S, Khan MN, Patel NR, et al. Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients. Laryngoscope. 2014;124(1):76–83.
   PubMed Web of Science ®Google Scholar
• Ansa B, Goodman M, Ward K, et al. Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973 to 2009. Cancer. 2013;119(14):2602–2610.
   PubMed Web of Science ®Google Scholar
• Youlden DR, Cramb SM, Peters S, et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol. 2013;37(6):770–779.
   PubMed Web of Science ®Google Scholar
• Sannigrahi MK, Sharma R, Panda NK, et al. Role of non-coding RNAs in head and neck squamous cell carcinoma: a narrative review. Oral Dis. 2018;24(8):1417–1427.
   PubMed Web of Science ®Google Scholar
• Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20(1):21–37.
   PubMed Web of Science ®Google Scholar
• Olatunji I. Potential application of tumor suppressor microRNAs for targeted therapy in head and neck cancer: a mini-review. Oral Oncol. 2018;87:165–169.
   PubMed Web of Science ®Google Scholar
• Yang CX, Sedhom W, Song J, et al. The role of microRNAs in recurrence and metastasis of head and neck squamous cell carcinoma. Cancers (Basel). 2019;11(3):395.
   Web of Science ®Google Scholar
• Kovarikova J, Baranova I, Laco J, et al. Deregulation of selected microRNAs in sinonasal squamous cell carcinoma: searching for potential prognostic biomarkers. Folia Biol (Praha). 2019;65(3):142–151.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Saiki Y, Shiga K, et al. miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis. Cancer Sci. 2012;103(9):1737–1743.
   PubMed Web of Science ®Google Scholar
• Kovarikova H, Bubancova I, Laco J, et al. Deregulation of selected microRNAs in sinonasal carcinoma: value of miR-21 as prognostic biomarker in sinonasal squamous cell carcinoma. Head Neck. 2017;39(12):2528–2536.
   PubMed Web of Science ®Google Scholar
• Xu G, Fang P, Chen K, et al. MicroRNA-362-3p targets PAX3 to inhibit the development of glioma through mediating Wnt/β-catenin pathway . Neuroimmunomodulation. 2019;26(3):119–128.
   PubMed Web of Science ®Google Scholar
• Assiri AA, Mourad N, Shao M, et al. MicroRNA 362-3p reduces hERG-related current and inhibits breast cancer cells proliferation. Cancer Genomics Proteomics. 2019;16(6):433–442.
   PubMed Web of Science ®Google Scholar
• Yuan J, Li T, Yi K, et al. The suppressive role of miR-362-3p in epithelial ovarian cancer. Heliyon. 2020;6(7):e04258.
   PubMed Web of Science ®Google Scholar
• Vlotides G, Eigler T, Melmed S. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev. 2007;28(2):165–186.
   PubMed Web of Science ®Google Scholar
• Hu ZG, Zheng CW, Su HZ, et al. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma. J Cell Biochem. 2019;120(6):9964–9978.
   PubMed Web of Science ®Google Scholar
• Wang W, Cao R, Su W, et al. miR-655-3p inhibits cell migration and invasion by targeting pituitary tumor-transforming 1 in non-small cell lung cancer. Biosci Biotechnol Biochem. 2019;83(9):1703–1708.
   PubMed Web of Science ®Google Scholar
• Liao LJ, Hsu YH, Yu CH, et al. Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions. Head Neck. 2011;33(5):719–726.
   PubMed Web of Science ®Google Scholar
• Ma K, Ma L, Jian Z. Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis. Oncol Lett. 2018;16(1):1107–1114.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Lechner M, Liu J, Lund VJ. Novel biomarkers in sinonasal cancers: from bench to bedside. Curr Oncol Rep. 2020;22(10):106.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222.
   PubMed Web of Science ®Google Scholar
• Kovarikova H, Chmelarova M, Palicka V. [The role of microRNA in head and neck cancer focusing on sinonasal carcinoma]. Cas Lek Cesk. 2016;155(2):45–50.
   PubMedGoogle Scholar
• Zhao Y, Wang X. miR-34a targets BCL-2 to suppress the migration and invasion of sinonasal squamous cell carcinoma. Oncol Lett. 2018;16(5):6566–6572.
   PubMed Web of Science ®Google Scholar
• Yu B, Qu L, Wu T, et al. A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2. Front Oncol. 2019;9:1575.
   PubMed Web of Science ®Google Scholar
• Nieto MA, Huang RY, Jackson RA, et al. Emt: 2016. Cell. 2016;166(1):21–45.
   PubMed Web of Science ®Google Scholar
• Expósito-Villén A, E. Aránega A, Franco D. Functional role of non-coding RNAs during epithelial-to-mesenchymal transition. ncRNA. 2018;4(2):14.
   Google Scholar
• Paolillo M, Schinelli S. Extracellular matrix alterations in metastatic processes. Int J Mol Sci. 2019;20(19):4947.
   Web of Science ®Google Scholar
• Maffeis V, Cappellesso R, Galuppini F, et al. Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition. Virchows Arch. 2020;477(2):241–248.
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang S, Shen H, et al. SP1/AKT/FOXO3 signaling is involved in miR-362-3p-mediated inhibition of cell-cycle pathway and EMT progression in renal cell carcinoma. Front Cell Dev Biol. 2020;8:297.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang X, Sun Y, et al. MicroRNA-362-3p inhibits migration and invasion via targeting BCAP31 in cervical cancer. Front Mol Biosci. 2020;7:107.
   PubMed Web of Science ®Google Scholar
• Cui L, Ren T, Zhao H, et al. Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells. Med Oncol. 2020;37(8):73.
   PubMed Web of Science ®Google Scholar
• Huang JL, Cao SW, Ou QS, et al. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Mol Cancer. 2018;17(1):93.
   PubMedGoogle Scholar
• Zhang E, Liu S, Xu Z, et al. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells. Tumour Biol. 2014;35(9):8801–8811.
   PubMedGoogle Scholar
• Shaker F, Nikravesh A, Arezumand R, et al. Web-based tools for miRNA studies analysis[J]. Computers in Biology and Medicine, 2020: 104060.
   Google Scholar